EPA Approves Spear®-Lep Bioinsecticide for Use on Outdoor Crops

Thursday, 20 September 2018

September 20, 2018 – (Kalamazoo, Michigan) – Vestaron Corporation today announces approval from the EPA of its Spear®-Lep bioinsecticide for control of lepidopterans in high- value field crops.

This approval makes Spear®-Lep the second peptide-based product developed by Vestaron, following the full EPA approval and subsequent commercial launch of Spear®-T for greenhouse crops this July.

The SPEAR® family of bioinsecticides offer an unprecedented insect control solution – providing the efficacy of a synthetic with the safety profile of a biologic. These products have a zero-day pre-harvest interval and are designed to be non-toxic to mammals, birds, fish, honeybees and other beneficial insects.

“We are pleased to add yet another environmentally favorable product to growers’ options for highly-effective pest control,” said Anna Rath, Vestaron’s Chief Executive Officer. “Spear®- Lep will for the first time offer Vestaron’s peptide-based, sustainable biopesticides to protect field-grown fruits, vegetables and other specialty crops against lepidopteran pests.”

Full commercial availability of the Spear®-Lep is expected in early 2019.

About Vestaron

Vestaron is a company dedicated to improving the safety, efficacy and sustainability of crop protection through migration from chemical pesticides to biological peptides. Vestaron is initially focused on a class of peptides that kill insect pests efficiently, but are safe for humans, birds, fish and the environment. As part of this, the company has developed fermentation- based peptide production and insect resistant crop platform that will allow it to develop a wide variety of biologic crop protection and trait products. Vestaron is the winner of the inaugural 2015 Bernard Blum Award for novel biocontrol solutions.

More information at www.vestaron.com

SPEAR® is a registered trademark of Vestaron Corporation.

Press Contacts

Greg Leaf (651) 271.2511 This email address is being protected from spambots. You need JavaScript enabled to view it.